Pa Shun International Holdings Ltd
HKEX:574
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| HK |
P
|
Pa Shun International Holdings Ltd
HKEX:574
|
95.9m HKD |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
117.1B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
69.7B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.2B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.9B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36B AUD |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.8B CNY |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -239 513 300% |
| 30th Percentile | -12.9% |
| Median | 0.5% |
| 70th Percentile | 5.3% |
| Max | 203 056% |
Other Profitability Ratios
Pa Shun International Holdings Ltd
Glance View
Pa Shun International Holdings Ltd. engages in the manufacture and distribution of pharmaceutical products. The firm operates through three segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceuticals to wholesalers, pharmacy stores, hospitals and other medical institutions, among others. Self-operated Retail Pharmacies segment is mainly engaged in pharmaceutical and healthcare products, cosmetic products and daily necessities in self-operated retail pharmacies. Pharmaceutical Manufacturing segment is engaged in the sales of pharmaceutical products manufactured by the Company.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Pa Shun International Holdings Ltd is -69.2%, which is below its 3-year median of -15.7%.
Over the last 2 years, Pa Shun International Holdings Ltd’s Net Margin has decreased from -60.4% to -69.2%. During this period, it reached a low of -69.2% on Jun 30, 2025 and a high of 34.9% on Jun 30, 2024.
